Given that NASH is a more serious process with inflammation, hepatocyte damage, or fibrosis, it has also been reported that upregulation of RCAN2 promotes inflammation and apoptosis (Luo et al., 2022). The gene discussed is RCAN2; the disease is metabolic dysfunction-associated steatohepatitis.